Pfizer Inc. (PFE) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
PFE EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PFE Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 70.3% | 24.7% | 12.4% |
| 2024 | 65.8% | 25.9% | 12.6% |
| 2023 | 50.9% | 8.9% | 3.6% |
| 2022 | 61.9% | 37.4% | 31.3% |
| 2021 | 57.7% | 25.6% | 27.2% |
Download Data
Export PFE earnings history in CSV or JSON format
Free sign-in required to download data
Pfizer Inc. (PFE) Earnings Overview
As of May 6, 2026, Pfizer Inc. (PFE) reported trailing twelve-month net income of $7.49B, reflecting -3.5% year-over-year growth. The company earned $1.31 per diluted share over the past four quarters, with a net profit margin of 12.4%.
Looking at the long-term picture, PFE's 5-year EPS compound annual growth rate (CAGR) stands at -3.5%, signaling declining earnings. The company achieved its highest annual net income of $31.36B in fiscal 2022.
Pfizer Inc. maintains positive profitability with a gross margin of 70.3%, operating margin of 24.7%, and net margin of 12.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including JNJ ($25.12B net income, 15.8% margin), MRK ($18.25B net income, 28.1% margin), ABBV ($4.23B net income, 6.9% margin), PFE has room to improve margins relative to the peer group. Compare PFE vs JNJ →
PFE Earnings vs Peers
Earnings metrics vs comparable public companies
PFE Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $7.77B | -3.1% | $15.44B | $1.36 | 12.4% | 24.7% |
| 2024 | $8.02B | +276.0% | $16.48B | $1.41 | 12.6% | 25.9% |
| 2023 | $2.13B | -93.2% | $5.29B | $0.37 | 3.6% | 8.9% |
| 2022 | $31.36B | +41.6% | $37.55B | $5.47 | 31.3% | 37.4% |
| 2021 | $22.15B | +141.8% | $20.79B | $3.88 | 27.2% | 25.6% |
| 2020 | $9.16B | -43.7% | $9.09B | $1.63 | 22.0% | 21.8% |
| 2019 | $16.27B | +45.9% | $7.51B | $2.87 | 39.5% | 18.2% |
| 2018 | $11.15B | -47.7% | $15.29B | $1.87 | 20.8% | 28.5% |
| 2017 | $21.30B | +195.3% | $14.39B | $3.52 | 40.5% | 27.4% |
| 2016 | $7.21B | +3.6% | $14.27B | $1.17 | 13.7% | 27.0% |
Full PFE Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See PFE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PFE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PFE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPFE — Frequently Asked Questions
Quick answers to the most common questions about buying PFE stock.
Is PFE growing earnings?
PFE EPS of $1.31 reflects slowing growth at -3.5%, below the 5-year CAGR of -3.5%. TTM net income is $7.5B. Expansion rate has moderated.
What are PFE's profit margins?
Pfizer Inc. net margin is +12.4%, with operating margin at +24.7%. Margins sit within typical range for the sector.
How consistent are PFE's earnings?
PFE earnings data spans 1989-2025. The current earnings trend is -3.5% YoY. Historical data enables comparison across business cycles.